Literature DB >> 2196402

Statistical modeling of the effects of drug combinations.

J L Plummer1, T G Short.   

Abstract

A method is described for identifying and quantitating departures from additivity (i.e., synergism and antagonism) when drugs having like effects are given in combination. It is applicable for both graded and quantal (e.g., after probit or logit transformation) responses. Log(dose)-response curves of both drugs should be linear but need not be parallel. The following model is fitted to dose-response data for both the individual drugs and combinations of drugs: Y = beta 0 + beta 1 log(A + P.B + beta 4(A.P.B)1/2) where Y is the response, A is the amount of drug A, B is the amount of drug B, and P is a relative potency of the drugs given by log(P) = beta 2 + beta 3 log(B'), in which B' is the solution to B' - B - A/P = 0. If log(dose)-response curves of the two drugs are parallel, beta 3 = 0, and P becomes a constant parameter to be estimated. A positive value of beta 4 corresponds to synergism and a negative value to antagonism. Hypothesis tests may be carried out to determine whether beta 4 is significantly different from zero.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196402     DOI: 10.1016/0160-5402(90)90058-s

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  7 in total

1.  Monotonic single-index models to assess drug interactions.

Authors:  Yubing Wan; Susmita Datta; J Jack Lee; Maiying Kong
Journal:  Stat Med       Date:  2016-11-02       Impact factor: 2.373

2.  Drug interaction: focusing on response surface models.

Authors:  Soo-Il Lee
Journal:  Korean J Anesthesiol       Date:  2010-05-29

3.  Reducing signs of aging and increasing lifespan by drug synergy.

Authors:  Xinhe Huang; Jun Liu; Bradley R Withers; Aaron J Samide; Markos Leggas; Robert C Dickson
Journal:  Aging Cell       Date:  2013-05-15       Impact factor: 9.304

4.  Evaluation of potential interactions involving trichothecene mycotoxins using the chick embryotoxicity bioassay.

Authors:  B A Rotter; B K Thompson; D B Prelusky; H L Trenholm
Journal:  Arch Environ Contam Toxicol       Date:  1991-11       Impact factor: 2.804

5.  Drug synergy drives conserved pathways to increase fission yeast lifespan.

Authors:  Xinhe Huang; Markos Leggas; Robert C Dickson
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

6.  Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.

Authors:  Saber Dini; Sophie Zaloumis; Pengxing Cao; Ric N Price; Freya J I Fowkes; Rob W van der Pluijm; James M McCaw; Julie A Simpson
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

7.  Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis.

Authors:  Xenofon Papanikolaou; Sarah Johnson; Tarun Garg; Erming Tian; Ruslana Tytarenko; Qing Zhang; Caleb Stein; Bart Barlogie; Joshua Epstein; Christoph Heuck
Journal:  Oncotarget       Date:  2014-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.